Identifying metabolic features of colorectal cancer liability using Mendelian randomization

Author:

Bull Caroline123ORCID,Hazelwood Emma12ORCID,Bell Joshua A12,Tan Vanessa12ORCID,Constantinescu Andrei-Emil12,Borges Carolina12,Legge Danny3ORCID,Burrows Kimberley12,Huyghe Jeroen R4ORCID,Brenner Hermann567,Castellvi-Bel Sergi8,Chan Andrew T910111213,Kweon Sun-Seog1415,Le Marchand Loic16,Li Li17,Cheng Iona1819,Pai Rish K20,Figueiredo Jane C21,Murphy Neil22,Gunter Marc J2223,Timpson Nicholas J12,Vincent Emma E123ORCID

Affiliation:

1. MRC Integrative Epidemiology Unit at the University of Bristol

2. Population Health Sciences, Bristol Medical School, University of Bristol

3. Translational Health Sciences, Bristol Medical School, University of Bristol

4. Public Health Sciences Division, Fred Hutchinson Cancer Center

5. Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ)

6. Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)

7. German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)

8. Gastroenterology Department, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), University of Barcelona

9. Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School

10. Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School

11. Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School

12. Broad Institute of Harvard and MIT

13. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University

14. Department of Preventive Medicine, Chonnam National University Medical School

15. Jeonnam Regional Cancer Center, Chonnam National University Hwasun Hospital

16. University of Hawaii Cancer Center

17. Department of Family Medicine, University of Virginia

18. Department of Epidemiology and Biostatistics, University of California, San Francisco

19. University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco

20. Department of Pathology and Laboratory Medicine, Mayo Clinic

21. Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center

22. Nutrition and Metabolism Branch, International Agency for Research on Cancer

23. Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London

Abstract

Background:Recognizing the early signs of cancer risk is vital for informing prevention, early detection, and survival.Methods:To investigate whether changes in circulating metabolites characterize the early stages of colorectal cancer (CRC) development, we examined the associations between a genetic risk score (GRS) associated with CRC liability (72 single-nucleotide polymorphisms) and 231 circulating metabolites measured by nuclear magnetic resonance spectroscopy in the Avon Longitudinal Study of Parents and Children (N = 6221). Linear regression models were applied to examine the associations between genetic liability to CRC and circulating metabolites measured in the same individuals at age 8 y, 16 y, 18 y, and 25 y.Results:The GRS for CRC was associated with up to 28% of the circulating metabolites at FDR-P < 0.05 across all time points, particularly with higher fatty acids and very-low- and low-density lipoprotein subclass lipids. Two-sample reverse Mendelian randomization (MR) analyses investigating CRC liability (52,775 cases, 45,940 controls) and metabolites measured in a random subset of UK Biobank participants (N = 118,466, median age 58 y) revealed broadly consistent effect estimates with the GRS analysis. In conventional (forward) MR analyses, genetically predicted polyunsaturated fatty acid concentrations were most strongly associated with higher CRC risk.Conclusions:These analyses suggest that higher genetic liability to CRC can cause early alterations in systemic metabolism and suggest that fatty acids may play an important role in CRC development.Funding:This work was supported by the Elizabeth Blackwell Institute for Health Research, University of Bristol, the Wellcome Trust, the Medical Research Council, Diabetes UK, the University of Bristol NIHR Biomedical Research Centre, and Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work used the computational facilities of the Advanced Computing Research Centre, University of Bristol - http://www.bristol.ac.uk/acrc/.

Funder

Wellcome Trust

Medical Research Council

Diabetes UK

Cancer Research UK

Publisher

eLife Sciences Publications, Ltd

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3